Buy Crypto Markets Spot FuturesGOLD Earn Event Center

OTTAWA, Ontario–(BUSINESS WIRE)–INOVAIT, Canada’s image-guided therapy and artificial intelligence network, launched the first installment of its Navigating theOTTAWA, Ontario–(BUSINESS WIRE)–INOVAIT, Canada’s image-guided therapy and artificial intelligence network, launched the first installment of its Navigating the

INOVAIT Launches Canadian Medtech Market Research Series

Author: AI Journal

Source: AI Journal

2026/02/10 23:03

2 min read

For feedback or concerns regarding this content, please contact us at [email protected]

OTTAWA, Ontario–(BUSINESS WIRE)–INOVAIT, Canada’s image-guided therapy and artificial intelligence network, launched the first installment of its Navigating the Canadian Image-guided Therapy (IGT) Sector Series—a comprehensive market research initiative chronicling the experiences of 30 Canadian IGT companies. Drawing on data analysis and in-depth interviews with company leadership, this series provides unique insights into one of Canada’s resilient and emerging medical technology sub-sectors.

The purpose of this series is to share the knowledge and experiences of IGT founders and executives who have navigated the challenges and opportunities of the Canadian IGT sector, thus helping guide and support others who may face similar obstacles and decisions in commercializing Canadian IGT or medtech.

The series will be released in multiple installments throughout 2026, each focused on critical industry topics. Today’s first part, “Funding & Investment,” delivers actionable insights on capital access in the Canadian IGT sector.

“The report analyzes diverse funding sources, explores candid perspectives on current government funding mechanisms from company leadership, and offers strategic recommendations to address the most pressing funding issues constraining sector growth,” says Dr. Philip Boyer, lead author of the market research series and Program Manager for the Health Data Innovation Program at INOVAIT. “Key findings reveal specific gaps in the funding ecosystem that, if addressed, could unlock significant economic opportunities and position Canada as a global leader in medical innovation.”

The report was officially unveiled at INOVAIT’s Discovery Forum, the organization’s flagship annual meeting held in Ottawa, where industry leaders, investors, and policymakers gathered to discuss the future of Canadian medical technology innovation.

Interested in the report? Visit the INOVAIT website to access Part 1 of the series: www.inovait.ca/reports

Contacts

[email protected]

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.